Cargando…

Patient and Healthcare Professional Satisfaction Ratings and Safety Profile of Sufentanil Sublingual Tablets for Treatment of Acute Pain: A Pooled Demographic Analysis

OBJECTIVE: This analysis reports the healthcare professional global assessment (HPGA) and patient global assessment (PGA) scores and the adverse event (AE) profile by age, body mass index (BMI), sex, and race from the three Phase III registration studies for sufentanil sublingual tablet (SST) 30 mcg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leiman, David, Jové, Maurice, Spahn, Gail Rosen, Palmer, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006952/ https://www.ncbi.nlm.nih.gov/pubmed/33790642 http://dx.doi.org/10.2147/JPR.S291359

Ejemplares similares

An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain
por: Hutchins, Jacob L, et al.
Publicado: (2018)

Abstract: Safety and Efficacy of Sufentanil Sublingual 30 mcg Tablets for the Treatment of Acute Pain following Outpatient Abdominoplasty
por: Lakshman, Shankar, et al.
Publicado: (2016)

Between evidence and commerce – the case of sufentanil sublingual tablet systems
por: Bantel, C., et al.
Publicado: (2017)

Sufentanil Sublingual Tablet Reduces Postoperative Opioid Use Following Outpatient Plastic Surgery
por: Seify, Hisham
Publicado: (2022)

Sufentanil Sublingual Tablet System for the Management of Postoperative Pain Following Open Abdominal Surgery: A Randomized, Placebo-Controlled Study
por: Ringold, Forrest G., et al.
Publicado: (2015)

A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
por: Koushik, Sarang S., et al.
Publicado: (2022)

Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
por: Seify, Hisham
Publicado: (2022)

Sufentanil Sublingual Tablet System vs. Intravenous Patient-Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active-Comparator Trial
por: Melson, Timothy I, et al.
Publicado: (2014)

Sufentanil sublingual tablet system (Zalviso(®)) as an effective analgesic option after thoracic surgery: An observational study
por: Fabio, Costa, et al.
Publicado: (2019)

Commentary on: Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
por: Kislevitz, Mikaela L, et al.
Publicado: (2022)

Erratum: Sufentanil sublingual tablet system (Zalviso®) as an effective analgesic option after thoracic surgery: An observational study
Publicado: (2020)

Sublingual Sufentanil Tablet System (SSTS-Zalviso(®)) for Postoperative Analgesia after Orthopedic Surgery: A Retrospective Study
por: Angelini, Andrea, et al.
Publicado: (2022)

Sufentanil sublingual tablet system for enhanced recovery after total knee arthroplasty: a prospective observational case study
por: Rineau, Emmanuel, et al.
Publicado: (2022)

Sublingual sufentanil for postoperative pain relief: first clinical experiences
por: Meijer, Fleur, et al.
Publicado: (2018)

Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
por: Scardino, Marco, et al.
Publicado: (2018)

Sufentanil Sublingual Tablet System vs. Intravenous Patient-Controlled Analgesia with Morphine: Postoperative Pain Control and Its Impact in Quality of Recovery
por: Fernandes, Diana L, et al.
Publicado: (2023)

Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study
por: Turi, Stefano, et al.
Publicado: (2019)

Sufentanil Sublingual for Acute Post-Operative Pain: A Systematic Literature Review Focused on Pain Intensity, Adverse Events, and Patient Satisfaction
por: Giaccari, Luca G., et al.
Publicado: (2020)

Preparation and evaluation of sublingual tablets of zolmitriptan
por: Prajapati, Shailesh T, et al.
Publicado: (2014)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets
por: Ma’ali, Anwar, et al.
Publicado: (2023)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Sublingual Sufentanil versus Standard-of-Care (Patient-Controlled Analgesia with Epidural Ropivacaine/Sufentanil or Intravenous Morphine) for Postoperative Pain Following Pancreatoduodenectomy: A Randomized Trial
por: Groen, Jesse Vincent, et al.
Publicado: (2022)

Sufentanil sublingual tablet system versus oral oxycodone for management of postoperative pain in enhanced recovery after surgery pathway for total knee arthroplasty: a randomized controlled study
por: Noel, Emmanuel, et al.
Publicado: (2020)

The statistical analyses of the study “Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study”[Letter]
por: Wang, Xiaohan, et al.
Publicado: (2019)

The Statistical Analyses Of The Study “Sufentanil Sublingual Tablet System (SSTS) For The Management Of Postoperative Pain After Major Abdominal And Gynecological Surgery Within An ERAS Protocol: An Observational Study” [Response To Letter]
por: Turi, Stefano, et al.
Publicado: (2019)

Formulation and evaluation of sublingual tablets containing Sumatriptan succinate
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

The impact of professional role and demographic characteristics on job satisfaction and retention among healthcare professionals in a military hospital
por: House, Sherita, et al.
Publicado: (2022)

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
por: Gunderson, Erik W., et al.
Publicado: (2016)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
por: Alyami, Hamad S, et al.
Publicado: (2021)

Sublingual sufentanil (Zalviso) patient-controlled analgesia after total knee arthroplasty: a retrospective comparison with oxycodone with or without dexamethasone
por: van Veen, David E, et al.
Publicado: (2018)

Sublingual Sufentanil vs. Intravenous Fentanyl for the Treatment of Acute Postoperative Pain in the Ambulatory Surgery Center: A Randomized Clinical Trial
por: Berg, Aaron, et al.
Publicado: (2022)

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
por: Schäfer, Udo, et al.
Publicado: (2017)

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use
por: Gawchik, Sandra, et al.
Publicado: (2014)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pp51ekj99u7ktgtp1ofpduvik1